US Stock MarketDetailed Quotes
ORTX Orchard Therapeutics
- 0.0000
- 0.00000.00%
Close Nov 26 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)22.76MShares16.720052wk High0.00P/B0Float Cap16.180052wk Low--Dividend TTM11.73MShs Float216.4000Historical High--Div YieldTTM0.00%Amplitude3.6010Historical Low--Avg Price1Lot Size
Orchard Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.09%6.3M | 67.45%7.31M | -77.61%1.24M | 1,252.54%22.66M | 1,346.38%6.99M | 384.65%5.78M | 4.37M | 5.52M | -35.45%1.68M | 483K |
| Operating revenue | 9.09%6.3M | 67.45%7.31M | -77.61%1.24M | 1,252.54%22.66M | 1,346.38%6.99M | 384.65%5.78M | --4.37M | --5.52M | -35.45%1.68M | --483K |
| Cost of revenue | 6.08%1.75M | 95.10%2.19M | -76.64%367K | 2,896.02%6.77M | 2.43M | 627.88%1.65M | 1.12M | 1.57M | -73.63%226K | 0 |
| Gross profit | 10.29%4.56M | 57.89%5.13M | -77.99%870K | 996.20%15.88M | 842.65%4.55M | 327.74%4.13M | 3.25M | 3.95M | -16.63%1.45M | 48,200.00%483K |
| Operating expense | -11.93%26.16M | -22.43%27.69M | -34.68%27.13M | 0.88%142.64M | -0.74%36.15M | -12.33%29.71M | -0.88%35.7M | 18.37%41.53M | -10.91%141.4M | -6.33%36.41M |
| Selling and administrative expenses | 0.05%11.61M | -19.94%10.99M | -16.27%11.14M | -10.34%48.79M | -18.89%10.6M | -11.01%11.6M | -3.74%13.73M | -5.35%13.3M | -16.26%54.42M | -19.46%13.07M |
| -Selling and marketing expense | -16.40%775K | -39.42%933K | 8.41%838K | -21.37%4.14M | -43.75%895K | -38.85%927K | 46.81%1.54M | -29.92%773K | -35.02%5.26M | -44.51%1.59M |
| -General and administrative expense | 1.48%10.83M | -17.48%10.06M | -17.79%10.3M | -9.16%44.66M | -15.44%9.71M | -7.35%10.68M | -7.75%12.19M | -3.26%12.53M | -13.59%49.16M | -14.09%11.48M |
| Research and development costs | -19.61%14.55M | -23.99%16.7M | -43.36%15.99M | 7.90%93.85M | 9.42%25.55M | -13.16%18.1M | 0.99%21.97M | 34.22%28.23M | -7.20%86.98M | 3.08%23.35M |
| Operating profit | 15.52%-21.61M | 30.47%-22.56M | 30.13%-26.26M | 9.43%-126.76M | 12.08%-31.59M | 22.31%-25.57M | 9.90%-32.45M | -7.11%-37.58M | 10.85%-139.95M | 7.57%-35.93M |
| Net non-operating interest income expense | 245.06%573K | 190.63%416K | 111.88%72K | 26.33%-1.54M | 87.74%-76K | 36.08%-395K | 4.38%-459K | -65.12%-606K | -343.29%-2.09M | -109.46%-620K |
| Non-operating interest income | 272.52%1.51M | 553.05%1.39M | 1,391.30%1.03M | 274.51%1.54M | 1,260.32%857K | 521.54%404K | 88.50%213K | -59.65%69K | -87.06%412K | -77.42%63K |
| Non-operating interest expense | 16.65%932K | 45.09%975K | 41.78%957K | 23.31%3.08M | 36.60%933K | 16.98%799K | 13.32%672K | 25.46%675K | 7.26%2.5M | 18.78%683K |
| Other net income (expense) | 41.31%-13.31M | 154.12%9.86M | 244.78%8.76M | -1,336.88%-24.74M | 6,828.44%22.66M | -461.25%-22.68M | -2,974.92%-18.23M | -545.66%-6.05M | -150.48%-1.72M | -94.20%327K |
| Gain on sale of security | ---8.8M | --8.21M | --3.85M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --0 | ---- | ---- | 31.20%-333K | --0 | --107K | ---- | ---- | ---484K | ---484K |
| -Less：Restructuring and merger&acquisition | --0 | ---- | ---- | -31.20%333K | --0 | ---107K | ---- | ---- | --484K | --484K |
| Other non- operating income (expenses) | 80.21%-4.51M | 109.10%1.66M | 181.13%4.91M | -1,871.73%-24.41M | 2,693.59%22.66M | -463.90%-22.79M | -2,974.92%-18.23M | -545.66%-6.05M | -136.29%-1.24M | -85.61%811K |
| Income before tax | 29.41%-34.34M | 75.98%-12.28M | 60.61%-17.42M | -6.45%-153.03M | 75.12%-9.01M | -29.46%-48.65M | -42.60%-51.14M | -29.75%-44.24M | 5.86%-143.76M | -8.02%-36.22M |
| Income tax | 190.04%976K | 111.42%25K | -120.69%-12K | -386.71%-2.37M | -1,010.48%-1.13M | 4.32%-1.08M | -129.20%-219K | -94.66%58K | 213.27%828K | 45.88%124K |
| Net income | 25.75%-35.32M | 75.83%-12.31M | 60.69%-17.41M | -4.20%-150.66M | 78.31%-7.88M | -30.51%-47.57M | -39.08%-50.92M | -25.91%-44.3M | 4.87%-144.58M | -8.11%-36.35M |
| Net income continuous Operations | 25.75%-35.32M | 75.83%-12.31M | 60.69%-17.41M | -4.20%-150.66M | 78.31%-7.88M | -30.51%-47.57M | -39.08%-50.92M | -25.91%-44.3M | 4.87%-144.58M | -8.11%-36.35M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 25.75%-35.32M | 75.83%-12.31M | 60.69%-17.41M | -4.20%-150.66M | 78.31%-7.88M | -30.51%-47.57M | -39.08%-50.92M | -25.91%-44.3M | 4.87%-144.58M | -8.11%-36.35M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 25.75%-35.32M | 75.83%-12.31M | 60.69%-17.41M | -4.20%-150.66M | 78.31%-7.88M | -30.51%-47.57M | -39.08%-50.92M | -25.91%-44.3M | 4.87%-144.58M | -8.11%-36.35M |
| Basic earnings per share | 59.46%-1.5 | 82.50%-0.7 | 65.71%-1.2 | -0.85%-11.8 | 79.31%-0.6 | -27.59%-3.7 | -37.93%-4 | -12.90%-3.5 | 23.53%-11.7 | 15.22%-2.9 |
| Diluted earnings per share | 59.46%-1.5 | 82.50%-0.7 | 65.71%-1.2 | -0.85%-11.8 | 79.31%-0.6 | -27.59%-3.7 | -37.93%-4 | -12.90%-3.5 | 23.53%-11.7 | 15.22%-2.9 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data